These results suggest persisting TWEAK can promote duct epithelial cell progenitors to differentiate into mature pancreatic cell types, including β-cells, and that the TWEAK-Fn14 interaction could potentially facilitate the production of new endocrine beta cells and provide clues for treating T2D [57] (Fig. 2). This evidence concerns the gene TNFSF12 and type 2 diabetes mellitus.